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A B S T R A C T   
Ethnopharmacological relevance: Ancient Egyptian texts only offer glimpses into their conceptual understandings 
of the inner-body and illness manifestation. Explanations of how prescribed materia medica were believed to work 
are rare and obscure, often resulting in modern approximations for ancient terminology such as ‘ra-ib’—an 
ancient Egyptian classification predominantly translated as ‘stomach’—leading to misunderstandings of histor-
ical texts, and therefore their use of pharmacology. 
Aim of the study: To investigate the ra-ib and the explanatory models of illness from the Egyptian perspective, and 
to explore the link between these and the prescribed selection of materia medica. To then compare the conceptual 
mechanics of these treatment strategies with those of another non-Western tradition—namely Traditional Chi-
nese Medicine (TCM)—to provide further insight into potential conceptual frameworks. 
Materials and methods: We conducted a case study of a unit of Ancient Egyptian texts focusing on the ra-ib. 
Totalling 34 prescriptions, the first stage lexicographically analysed the texts using cognitive linguistic and 
translation theories to produce our new understanding. This enabled our comparison of the mechanics of materia 
medica usage within these texts with those found in TCM outlined by the Pharmacopoeia of the Peoples Republic of 
Pharmacopeia of the People’s Republic of China 2015 for the relevant ingredients. 
Results: the study demonstrated that—rather than denoting the organ ‘stomach’–ra-ib instead constitutes a system 
running from the mouth, downward to the anus. This is best translated as ‘inner thoroughfare’, and changes the 
way in which we attempt to understand potential motivations in the selection of ingredients. By exploring 
common themes in the use of eleven securely translated ingredients from the Egyptian corpus and the Phar-
macopoeia of the People’s Republic of China—representing a modern traditional system which understands the 
body via a series of interconnected systems—we were able to highlight certain themes which might be ‘universal’ 
to system-based traditions; this provided new insights into the Egyptian motivations for treatment selection. 
Conclusions: Having gained the ancient view of the body and illness, cultural comparisons are important for 
providing further potential insights and clarifications of a discontinued historical healing tradition. The new 
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understanding of the ra-ib from our study greatly changes the way in which we understand the dynamics of 
Egyptian ethnopharmacological source material from this period.   
1. Introduction 
Healing practices from ancient Egypt are recorded in the native 
language on papyri and ostraca of varying sizes dating from as early as c. 
1900 BCE and at least as late as c. 250 CE (SAE, 2019). Larger 
well-preserved papyri from the late-second millennium BCE—including 
the Ebers and Edwin Smith Papyri—have been published in many lan-
guages over the past century, primarily in English (Ebbell, 1937), 
German, and French (notable recent translations include Bardinet, 1995 
and Westendorf, 1999; for a complete catalogue and discussion of 
publications, see SAE, 2019). These publications have made the texts 
accessible to the wider scientific community – from these, studies have 
focused particular attention to clinical reasoning for the use of materia 
medica in Egyptian healing compendia, particularly from modern 
biomedical understandings of anatomy and physiology (Campbell, 
2007, 2008; Aboelsoud, 2010). However, the ancient texts only offer 
glimpses into Egyptian understandings of inner-body mechanics and 
illness manifestation; explanations of how prescribed materia medica 
were believed to work are rare and obscure, presenting a significant 
challenge to ethnopharmacological research. In what ways can we 
re-access and understand the plethora of motivations for ancient treat-
ment selections? 
To explore this question, we conducted a case-study where we first 
re-translated and philologically examined a ‘series’ (a grouping of texts 
within a papyrus, linked by an overarching focus, such as a body-part – 
discussed in our materials and methods section) comprising thirty-three 
ancient Egyptian texts, to extract and understand Egyptian concepts of 
physiology, pathogenesis, and treatment strategy. Each text in this series 
focuses on the ancient ‘anatomical’ classification ‘ra-ib’ (r -jb, ; 
literally: ‘mouth of the heart’), a term primarily understood as denoting 
the ‘stomach’ in Egyptological scholarship (Ebbell, 1937; Westendorf, 
1999; Radestock, 2015; Lalanne and Métra, 2017; the online SAE project 
provisionally maintains the communis opinio; SAE, 2019), despite two 
proposals for an adjustment of this translation (Bardinet, 1995, who 
opted for a literal translation ‘l’entrée de l’intérieur-ib’; Walker, 1996, 
who ultimately translated ‘thorax’). As noted by Imhausen and Pom-
merening (2010), a literal translation could only make sense if the 
conceptual significance is correctly expounded in a commentary, 
whereas approximations using modern terminology are misleading as 
they do not adequately express the ‘Egyptian point of view’. This paper 
understands this ‘emic’ point of view of ra-ib and its relationship with 
ideas of pathogenesis as being crucial for questioning the potential 
motivations for ingredient selection in treatment strategies for the ra-ib. 
Rather than understanding the term to represent the ‘stomach’ 
organ, we re-evaluated ra-ib as represeting an interconnected organ 
‘system’ (Marieb and Hoehn, 2015) based on the implications provided 
by the series of texts. Our study thus needed to address three central 
questions: 1) to where did the limits of this system extend, 2) how was it 
conceptualised, and 3) what influence did this system have on the se-
lection of ingredients used to treat illnesses associated with it. It should 
be noted here that our answers to our first two questions were not ob-
tained based on our comparison, but solely by our methods of Egypto-
logical analysis outlined in the materials and methods section. That said, 
they are the basis for our comparison, and therefore need to be explained 
in detail. For the purpose of this introduction, the answer to our first 
question can be summarised as ‘a system running from mouth to anus’, 
or—as the term is translated here based on the Egyptian compound ra-ib 
itself—‘the inner thoroughfare’. However, as our results show, it was 
more diverse than the Western notion of a ‘digestive system’, as the ra-ib 
constituted an ancient Egyptian ‘explanatory model’ (Quinlan, 2015) 
used to explain a diverse range of clusters of symptoms, each being 
unique to one particular text within the ra-ib series. This fact raised more 
questions concerning the potential motivations for the selection of 
treatment strategies, than it would were ra-ib to represent more reduc-
tionist classifications such as ‘stomach’ or ‘thorax’. The systemic nature 
of ra-ib provided a rationale for our ethnopharmacological comparison 
with the principle and application of Traditional Chinese Medicine 
(TCM), the results of which we present here. 
Though it has been noted by Unschuld that ‘it is not possible to give a 
single definition of “traditional Chinese medicine” either in China or in 
the West’ (Unschuld, 2018, 142), TCM’s unique and recognisable gen-
eral ideas of the body and health regulation, such as ‘theories about qi, a 
vital energy, which is said to flow along channels called meridians and 
help the body to maintain health’ remain central characteristics of its 
‘different approach’ (Schroën et al., 2014; Cyranoski, 2018; here 
referred to as ‘perspective’, after Kuriyama, 2002). The Pharmacopoeia of 
the People’s Republic of Pharmacopeia of the People’s Republic of China 
(2015) (PPRC)—the main point of reference of herbal drugs used ac-
cording to TCM principles—references this unique perspective of the 
human body, for example where a plant’s ‘meridian tropism’ is listed 
(PPRC, 2015). Such an entry relies on the user’s acquaintance with 
TCM’s perspective that qi, meridians (better termed ‘conduits’, as the 
former is a ‘standard translation’ now considered ‘unsuitable and 
misguided’, Unschuld, 2018, 125), and ‘organ systems’ (Scheid, 2018) 
such as the ‘spleen-stomach system’, which is ‘not synonymous with the 
spleen in Western medicine anatomically’ (Wu, 1998; see also Rui-xin 
and Yue yun, 2019; Yuan and Xiaobei, 2020), are central to the objec-
tives of physicians when they ‘tong in clinical practice’: ‘“diffusing ob-
structions” (xuan bi宣痹), “moving areas of stagnation” (xing zhi 行滯), 
“eliminating stasis” (qu yu 去瘀), and “purging” (gongxia 攻下) via the 
intestines or urination’ (Scheid, 2018, 139). These features of the more 
systemic perspective offered in TCM, and therefore that of the use of 
herbal medicine by PPRC, is culturally specific and not—as with the 
Egyptian term ra-ib—directly translatable, a ‘basic issue that any 
attempt at cross-cultural exploration faces’ (Lloyd, 2015). To circum-
vent this, we first gained a clearer indication of the types of illnesses in 
each unique text in the ra-ib textual series, and then sought only to 
compare those illness context(s) for which each Egyptian ingredient was 
prescribed with the context where the same ingredient occurs in the 
PPRC (2015). 
This investigation was conducted with an objective of exploring the 
significance of potential ‘cross-cultural patterning’ or ‘relative univer-
sals’ (Trigger, 2003; Pommerening and Bisang, 2017; Althoff et al., 
2019, 15–16). By relative universals, we mean similar concepts that 
have arisen or can arise at any time and in any place independently, i.e. 
irrespective of cultural contacts, with identical or comparable objects, 
properties, or practices. Thus the definition only calls for independent 
emergence in places that have not been in contact with each other. In 
our case concerning the selection of natural ingredients for treating 
symptoms, we are using two temporally and geographically discon-
nected cultures—one modern (China), one ancient (Egypt)—to mini-
mise the chance that any identified potential universal be the result of 
cross-cultural or historical influences. This investigation into univer-
sals was not restricted to a simple identification of similar or dissimilar 
use patterns for corresponding materia medica, but more significantly to 
survey the role interconnected systems play in the cultural con-
ceptualisation of treatment efficacy, and the implications this might 
have on our interpretation of possible motivations for ingredient selec-
tion in ancient Egyptian medicine. 
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2. Materials and methods 
Within Egyptian healing papyri, constituent texts are oftentimes 
thematically categorised into ‘series’ or units of texts with a particular 
focus, and the ordering and organisation of these series within a 
particular papyrus varies depending on principles that still have to be 
examined further (Pommerening, 2017a). The subject of our investiga-
tion is the large coherent group of recipes dedicated to ra-ib. Thirty-three 
texts form one such series within the Ebers Papyrus (a document con-
taining over 850 individual texts organised by theme into a variety of 
series, dated primarily by palaeography to c. 1550 BCE). They are all 
headed under the title šs .w n mn r -jb ‘wisdom/experience of one 
suffering from the ra-ib’; . The ra-ib series provides a rationale for 
research, not only for its limited size of manageable data, but more 
significantly for the more detailed content of the series. Each text pro-
vides a unique series of illness-specific symptomatic and diagnostic in-
formation, followed by a treatment strategy tailored to that complex of 
symptoms (see supplement). A further ra-ib text—the only other 
example with an identical format—is included on the verso of the Edwin 
Smith Papyrus—dated to the same period. Compared with the texts 
found in the ra-ib series of the Ebers papyrus, those of the surrounding 
series are significantly less detailed, (being largely formulated more 
simply with variants of: pẖr.t n.t X ‘a remedy of X’ – where X represents 
an illness classification and the region of the body in which it was un-
derstood to manifest). These simple titles are followed immediately by 
instructions for preparing the remedy). 
We first reproduced a transliteration of the text from the original 
hieratic-script (images from the online archives of the UBL (2019) and 
the NLM (2019)) and a retranslation according to modern Egyptological 
conventions and standards for translating ancient scientific texts (Allen, 
2014; Pommerening, 2016a). These are attached in the supplement to 
our paper (see supplement). Each prescription entry includes an image 
of the original hieratic text, its transliteration into computerised hiero-
glyphic, the Egyptological transcription code of the sign-groups, and 
finally a translation; this was to enable the research to detect sign var-
iations for seemingly identical terms indicating semantic shifts, as well 
as to allow the scientific procedure to be properly reproduced (for the 
proper conduct for researching historical texts, see Jütte et al., 2017; for 
ethnopharmacological research see the consensus paper by Heinrich 
et al., 2018). In the transcriptions and translations of the source material 
listed in the appendix, the texts are sectioned into title, symptom clause 
(s), diagnosis, treatment, and (if present) further information. Though 
these are not headed in the original document, structural markers make 
clear these distinct sections within the texts (Pommerening, 2016a). 
Such markers can be identified by the use of red ink by the ancient 
scribe—contrary to the black ink used elsewhere—to highlight the title 
of each text within the series, the diagnosis marker ‘then you would have 
to say X’ (where X is the diagnosis: ḏd.ḫr=k r=f X), and treatment 
introduction marker ‘you would have to make X’ (where X is the treat-
ment strategy: jri.ḫr=k X). Red ink was also used to highlight the precise 
measurement prescribed for each ingredient. The ink colours are repli-
cated in our transliteration, transcription, and translation using red and 
black fonts (see supplement). In accordance with current research, the 
measurements are noted in the ancient Egyptian dyadic fractions of dja 
(c. 300 ml) and oipe (c. 19.2 l) (Pommerening, 2005; see supplement). 
As translating classifications of materia medica is particularly chal-
lenging for the study of any ethnomedicine, written or otherwise (Berlin, 
1992; Lardos, 2015), exerted efforts were taken to ensure that the in-
gredients translated and compared in this study fit the identification 
criteria outlined in the recent guidelines set by Pommerening (2016b). 
In cases where a translation is not possible, the ingredient’s rendering in 
the transcription code (for example: š š , a modern code applied to 
represent the phonemes in the Egyptian spelling of the classification 
‘ ’), together with the superordinate level of classification 
marked by the original script’s use of a ‘determinative’ (a symbol which 
serves to further classify a word, i.e.: –plant/herb, - 
fruit/seed/powder/mineral etc., -grain, and -liquid/viscous/salve--
like product; for example ‘̌s š -fruit/seed/powder/mineral’), is used as a 
substitute (Pommerening, 2016a, 2017a). Modern Latin binomials for 
plants are according to The Plant List (TPL, 2020; some entries include 
further designations following ‘syn.’ – these designations are those 
encountered in either the Egyptological literature or the PPRC that are 
considered a synonym of the ‘accepted’ name by TPL), and were ac-
quired based on the approaches to materia medica translations outlined 
by Pommerening (2016b), which—among many other fundamental 
approaches—considers flora accessible in ancient times as supported by 
the archaeobotanical evidence (de Vartavan and Amorós, 1997). 
While it is clear that ingredients used in treatment strategies were 
thought of as independent entities with their own paradigms of appli-
cation (for discussions of herbal knowledge and the use of simples, see: 
Dawson, 1929; Betro, 1988; Tait, 1991; Ryholt, 2019), it should be 
noted that in the majority of Egyptian texts examined, the selected in-
gredients were combined with others, if not at least a type of oil, alco-
holic substance, honey, or water (as is also common practice in TCM – 
the term is named ‘processing’) – excipients or solvents used for com-
bination with herbal materials can be considered as an extraction pro-
cedure and will have significant impact on both bioavailability and 
bioactivity, reflecting on both the efficiency and safety of the materia 
medica, (Pommerening, 2006; Zhao et al., 2010; Chang et al., 2011; 
Wang and Franz, 2014). Addressing this issue in a detailed manner 
would excessively extend the scope of our investigation; therefore, with 
one exception, our focus was only to compare the contexts in which the 
materia medica occur in order to contribute an insight into the potential 
motivations of the initial selection of a singular ingredient within the 
composition, rather than to further elaborate on the motivations and 
pharmaceutical effect resulting from combining ingredients. The one 
exception is found in our discussion of the use of Hordeum vulgare L. in 
Ebers 206. In stark contrast to the remaining texts studied which list only 
the ingredients and the oils or liquids with which they are combined, 
Ebers 206 is uncharacteristically specific about the processing of this one 
ingredient, enabling our investigation to probe slightly deeper in our 
comparative analysis. 
Following the translation process, a lexicographic analysis was 
conducted to determine the semantic fields of the two elements in the 
compound noun ra-ib – this used the comprehensive Thesaurus Linguae 
Aegyptiae (TLA, 2019) online research tool, an open-access lexicographic 
database in which ancient Egyptian lexemes and their occurrences 
(complete with references) can be searched. With this, our investigation 
into the three questions concerning the limits of the ra-ib system, its 
conceptualisation, and how this influenced the selection of treatment 
strategies within the Ebers and Edwin Smith papyri was then made 
possible. Ethnomedical traditions are the product of a balance between 
the biophysically observable and the human/cultural frameworks 
within which they operate (Kleinman, 1973; Quinlan, 2015); therefore, 
the application of conceptual metaphor theory (Lakoff and Johnson, 
1980) to certain passages proved useful for gaining a general sense of the 
types of human experience (the ‘source domain’) which influenced the 
visualisation of ra-ib (the ‘target domain’), thereby allowing further 
gleanings toward an emic perspective. 
From this, it was possible to better determine the relationship be-
tween the nature of the symptoms and the systemic model used to 
explain them, further elucidating the significant variation in the appli-
cation of materia medica in this series of texts. This information could be 
compared with that supplied by the PPRC (2015) which—together with 
the supporting research publications cited—outline how and why such 
natural products are employed in TCM. Where an ingredient prescribed 
in a text from the ra-ib series occurred in the PPRC, we noted the types of 
symptoms cited in that particular text within the ra-ib series, and the 
parts of the body in which those symptoms manifested. Similar infor-
mation (albeit concise and ‘modern’ in format) was then provided by the 
PPRC for comparison. By collecting and comparing the available infor-
mation surrounding the use of each corresponding ingredient from the 
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two disconnected sources, we were able to consider the significance of 
potential universals, specifically with regard to the impact a 
system-based dynamic might have on the selection of materia medica in 
the Egyptian texts. 
In contrast with far more extensive studies between historical tra-
ditions, examining more explicit and better documented material, as 
conducted by Kuriyama (2002) and Lloyd and Sivin (2003), we inten-
tionally sought to use a modern tradition with accessible users for 
comparison with the comparatively inexplicit Egyptian source material. 
While future investigations are planned, comparing Egypt with other 
historical traditions, such as those temporally or geographically closer to 
ancient Egypt—i.e., Hippocratic, Galenic, and medieval European or 
Middle-Eastern traditions—would be problematic to our aim of grasping 
the significance of universals in disconnected traditions at this stage. 
The extent to which Egyptian medicine influenced later Hippocratic 
sources is still debated (see Steuer and Saunders, 1959; Ritner, 2007; cf. 
von Staden, 1989; Jouanna, 1999), and—historically speak-
ing—classical and medieval sources are diachronically linked to some 
degree (Craik, 2015; Nutton, 2013; Pormann and Savage-Smith, 2007). 
Furthermore, while it is clear in cases that some ideas had already been 
transmitted between these regions and China (and vice-versa) in ancient 
times (e.g. Heydari et al., 2015; see also Unschuld, 2018, who even 
suggests that ‘it may be that the name Qi Bo [the healer named in the 
ancient Chinese medical text Huang di nei jing su wen, first or second 
century C.E (Unschuld, 2018).] is a faint echo of the name Hippo 
[crates], pp. 20–21), the actual extent of the influence is yet unknown. 
For now, the significant temporal and geographic disconnection be-
tween c. 1550 BCE and modern TCM can be reason enough to avoid 
discussions of diachronic and cross-cultural transmission. 
3. Results and discussion 
The title of each text in the ra-ib series is a variant of: ‘if you examine 
a man because of the suffering of an obstruction of the ra-ib’ (Russell, 
2019); therefore, ‘an obstruction’ of the ra-ib is the common focus of 
each text. Before outlining the rationale of our new understanding of 
ra-ib, it is first necessary to clarify the nature of ‘obstruction’, or perhaps 
‘blockage’, represented by the Egyptian word shena (̌sn ) (TLA, 
2019). Following the three phonetic hieroglyphs which spell out the 
radicals of this noun (that is, its constituent consonants, as the hiero-
glyphic script does not mark vocalics) is its ‘classifier’, the so-called 
‘flesh-determinative’: . This indicates that it was in some way con-
ceptualised as being part of or related to the body or its anatomical 
structures, or at least that it denotes a ‘fleshy’ or ‘meaty’ substance to a 
certain extent (see Pommerening, 2017a). The precise fabric of the 
obstruction varies depending on the text within the ra-ib series – it can 
be an obstruction of food (Eb. 188, 189, 205, 207, and 211); specified or 
unspecified bodily substances which ‘knot’ (ṯs) and ‘uplift’ (ṯsi), e.g. 
blood, faeces, and pus (Eb. 190, 193, 198, 202, 203, 204); con-
ceptualised substances which are, or can in the Egyptian view become 
pathogenic (such as st.t and wḫdw) (Eb. 192, 195, 199, 200, and 206); or 
caused by the spirits of deceased ancestors or demons (Eb. 191, 194, 
201, and 209) (Russell, 2019). These specifications of the obstruction, 
when present, are often found in the diagnostic clauses of a text within 
the series, for example in Ebers 193: ‘it is a swelling of faeces which has 
not yet knotted’ (sḫn pw n ḥs nj ṯs.t=f), Ebers 192: ‘it is the putrefaction of 
his st.t-bodily-fluid which cannot descend to his groin with his st. 
t-bodily-fluid’ (sḥw w pw n.w st.t=f nj h i.n< =f> r npḥ.w=f), and Ebers 
196: ‘it is a ḥnw.t-accumulation of raised-matter which cannot be 
brought up’ (ḥnw.t pw n.t ṯs.w nj sṯs.n.tw=f) (see supplement). While 
many of the terms in these extracted clauses are yet obscure to us (such 
as ‘st.t-bodily-fluid’ or ‘ḥnw.t-accumulation’), the 
superordinate-classification ‘obstruction’ is diverse. Furthermore, the 
latter two examples further illustrate the need for this obstruction to 
descend (h i) or be brought up (sṯs.tw) to restore health, a notion espe-
cially evident in expressed purposes of remedies such as in Ebers 198: 
‘you have to make it [the obstruction] descend (h i) with a remedy’ (rḏi. 
ḫr=k h i<=f> m pẖr.t). These extracts imply a particular emphasis on 
the restoration of health by removing an obstruction of the ra-ib. 
The term ra-ib itself is a compound noun consisting of ra (r , ) 
‘mouth/opening’ (TLA, 2019), and ib (jb, ) ‘metaphorical heart’ 
(Nyord, 2009; cf. haty (ḥ .ty, ) ‘physical heart’, Nyord, 2009; TLA, 
2019; cf. Bardinet, 1995, ‘l’entrée de l’intérieur-ib’). As noted by Walker 
(1996), the term ra denotes more than the physical lips to include the 
oral cavity (from whence he posited the translation ‘thorax’, or more 
literally ‘cave of the heart’). Our analysis found that the ra-ib compound 
noun belonged to a series of Egyptian classifications which denote 
something even less spatially restricted than the notion of a cavity or 
‘cave’; this will here be labelled the ‘ra-X paradigm’. A search of these 
within Egyptological dictionaries (TLA, 2019) produces a list of desig-
nations for compound nouns composed in the first element with ‘ra’, 
‘mouth/opening/door’ (r , ); the spatial limitations of which should 
be understood as specific to the compound noun in question, as the 
classification was not as spatially restricted as in the English or German 
sense. Instead, it was observed that compound nouns of the ra-X para-
digm also include designations denoting passageways or thoroughfares, 
as in names for topographical features such as r -hnw, the ‘opening of the 
hnw-mountains’ – the ancient name for the Wadi Hammamat, a natural 
corridor of over 200 km formed by a dry river-bed connecting the Red 
Sea and the Nile, (locative qualifications could also be applied, as in ḥr.y 
r -hnw the ‘Upper region of the opening of the hnw-mountains’). Des-
ignations from conceptual domains also employ the ra-X paradigm: 
r -sṯ w, the name for a region of the underworld literally meaning 
‘opening of dragging’, was conceptualised and even depicted in funerary 
texts and illustrations as a thoroughfare through which the barque of the 
sun-god Re was dragged during his nightly journey through the Neth-
erworld (Fig. 1) (Hornung, 1963; Richter, 2008). Spatially obscure 
designations also occur, such as r -ḥn.t ‘the opening of the Fayyum’, the 
ancient name for the modern settlement of el-Lahun, which straddled 
the waterway between the main flow of the Nile and the Fayyum Oasis. 
Regardless of spatial obscurities, a classification within this paradigm is 
characterised by an ‘A to B’ dynamic: thus, r -hnw, the Nile (A) to the 
Red Sea (B); r -sṯ w, the realm of the living (A) to the realm of the dead 
(B); and r -ḥn.t, the Nile (A) to the Fayyum (B). As the lexical compo-
nents of ra-ib fit the ra-X classificatory paradigm, thus denoting a pas-
sage and not an opening, we were able to return to our three questions: 
1) what were the limits of this system; where did A begin and B end, 2) 
how was the inner trajectory conceptualised, and finally 3), how did this 
conceptualisation influence the action of selecting treatment strategies? 
An answer to question 1) can be found through an examination of the 
frequency with which other anatomical terms (marked in writing with 
the use of a flesh-determinative) occur within the texts. This highlights 
the types of issues categorised as problems with the ra-ib, such as pain/ 
discomfort of upper joints, lower joints, and symptoms which man-
ifested upon the back, or with the nose and eyes, as well as the areas 
through which treatments for the ra-ib were believed to descend – 
notably from mouth to anus. The examination also indicated areas of 
higher association, such as the mouth, rear, belly and metaphorical heart 
(jb). If we accept ra-ib belonging to the ra-X paradigm, then ra-ib appears 
to mark a spatial entity between the mouth (A) and rear (B) – a thor-
oughfare through the metaphorical heart (jb) and belly/body (ẖ.t) of a 
human being. This clearly denotes a term less reductionist than ‘stom-
ach’ in the biophysical sense or a colloquial general sense, and a more 
systemic model such as perhaps the Western notion of the ‘digestive 
system’. However, while many of the descriptions of anatomical func-
tions seemingly pertain to a digestive capacity, assuming the term is the 
exact equivalent of the modern notion is misleading. While the symp-
toms of an obstructed ra-ib manifested as pain and discomfort in areas 
which might conjure notions of a modern ‘digestive system’, such as the 
metaphorical heart (jb , Eb. 188, 196, 198, 205, 206, and 207), the 
‘abdomen’ (h ̱.t , Eb. 188, 189, 197, 205, and 207), the ‘intestines’ (q b 
J. Russell et al.                                                                                                                                                                                                                                  
Journal of Ethnopharmacology 265 (2021) 113115
5
m Ꜥ , literally: ‘the actual coils’; Eb. 191, 194, 204, and 
208), and the rear-end/anus (pḥw.yt , Eb. 188, 191, 194, 198, and 
207), they extend beyond this to include the manifestation of symp-
toms—suggesting a direct or indirect connection—with the eyes/nose/ 
face (jr.ty/fnḏ/ḥ t / / , Eb. 192 and 195), the upper arm and 
breast region (g b/mnḏ / Eb. 191 and 194), the physical 
heart (h ty , Eb. 219 and 220), the extremities (ꜥ.t , Eb. 189 and 
205, see also legs, wꜥr.ty , Eb. 206), the skin (ḥꜤ.w , Eb. 197), 
the back (psd , Eb. 200) and the uterus (jd.t , Sm. v), among 
others (see supplement). 
The answer to question 2) can be accessed by applying conceptual 
metaphor theory as first posited by Lakoff and Johnson (1980) to 
informative passages of the text, the source domains from which the 
ra-ib is visualised are more complex than a simple biophysical obser-
vation of digestion and defecation. Such passages as in Papyrus Ebers (in 
the following abbreviated as Eb. with a text number following West-
endorf, 1999) Eb. 198 ‘you will find it (the obstruction) having clogged 
and crossed over the canal, his metaphorical heart (jb) is narrowed and 
his ra-ib is parched’ exhibit visualisations, which originate in a society 
primarily grounded in a riverine environment (for other clear examples, 
see Eb. 204 and 205 in the supplement). The restriction to travel 
resulting from the ‘clogging’ (ḏb ) of a ‘canal’ (mr) in this riverine 
environment can be seen in an inscription marking the restoration of a 
canal during the reign of Tuthmosis III, who found a canal (mr) clogged 
(ḏb ) with stone (Gasse and Rondot, 2007). The terminology used in our 
source material mirrors that used to explicate a circumstance in which 
an obstruction prevents transportation through a canal, the difference 
being the fabric of the obstruction in the ra-ib, as noted above, which is 
of course more body-specific. As the ancient Egyptian lived experience 
was dependant on the flow of the Nile, it is unsurprising to find riverine 
metaphors (‘source domains’) being used to visualise more obscure 
‘target domains’ (Lakoff and Johnson, 1980) such as inner bodily 
functions. 
Obtaining a sound answer to question 3)—how the Egyptian model 
of ra-ib influenced the selected treatment strategies—is an even more 
complex challenge. Gleanings toward focus and intent of prescribed 
remedies can—in a few cases—be extracted from short descriptions of 
medicaments in the texts. For example, in Eb. 188 it can be deduced 
from the symptoms ‘he finds it heavy/difficult to eat bread’, and the 
directions ‘the man drinks (the remedy) for four days until you empty 
out his belly’ that the digestive capacity of the system is the singular 
focus. This remedy uses an unknown ingredient and date seeds (Phoenix 
dactylifera L.), which are mashed and strained with water. While one 
cannot elaborate further on the unknown ingredient (p ḫ-sr.t), one might 
speculate that perhaps the rationale behind the application of date seeds 
(P. dactylifera) is found in its ability to stimulate digestion due to pres-
ence of polyphenols in that seed (Sirisena et al., 2018). The diagnosis 
clause interprets this as a ‘thing (i.e. condition) of the miset (mjs.t, likely 
to be translated as liver: TLA, 2019)’, suggesting it is this area of the 
body which is either part of, or at least connected to the ra-ib system. The 
symptoms described and treated are categorised within the ra-ib 
explanatory model with specific focus on its relation to the liver (miset). 
Suggesting that each ra-ib remedy is therefore digestive in nature is 
problematic: ingredients applied elsewhere in the source material are 
diverse, and no two treatment strategies are identical. Eb. 192 and 194 
list symptoms manifesting especially as vomiting and inflammation in 
Fig. 1. Amduat rosetau.  
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the eyes and a running nose – the diagnosis explains that this is caused 
by the putrefactive substance setet (st.t ) not being able to descend 
to the patient’s groin-area (npḥ.w ). The remedy for this is to be 
taken ‘until his eyes open and his congestion departs and is descended 
with the setet-substance’ – it includes an indeterminable type of grain- 
based cake or bread, and wormwood (Artemisia absinthium L.), which 
is placed in a vessel and filled with onion (Allium cepa L.), all of which is 
finally processed with beer and then eaten with the fatty flesh of a cow 
and an indeterminable class of beer. Here, the model explaining the 
occurrence of these symptoms is an obstruction to the regular descent of 
setet through the ra-ib. However, are the selected ingredients again 
motivated by stimulating digestion? It is especially interesting here that 
this is the only use of onion (A. cepa) within these texts; perhaps one 
could speculate the reaction of the eyes to chopped onion contributed 
sympathetic significance – if indeed we are to understand the individual 
symptoms (and not the system-based explanatory model) motivated the 
treatment prescribed in each case. The diversity of the variables 
obscuring the answers to question 3) thus motivated our investigation 
into the significance of potential universals in the conceptualisation of 
treatment efficacy in systems-based models. 
In comparing Egyptian materia medica with those which correspond 
to entries in the PPRC, we found eleven securely translatable ingredients 
(Table 1). One ingredient corresponded at both a superordinate and 
subordinate level – Hordeum vulgare L. The remaining entries are variant 
subspecies of corresponding genera according to Linnaeus’s plant tax-
onomy. It should be noted that while many subspecies have shared 
therapeutic applications such as anti-inflammatory and anti-pain effects, 
the therapeutic effects of plants are attributed to their secondary me-
tabolites effected by both genetic variations and environmental growth 
conditions (Wink, 2015). 
The nature of the correspondences between the PPRC and the ra-ib 
cases presented a variety of results. Firstly, many of the entries show 
significant differences in the purposes for which they are employed. The 
differences in usage patterns found could be attributed to any number of 
variables (cf. Pommerening, 2017b for Egyptian use of analogy) – a 
more detailed evaluation of these was outside the parameters of our 
case-study as it requires at the very least a complete study of more than 
800 remedies which constitute the Ebers Papyrus. 
The investigation presented five parallels, which were unique in the 
questions they raised of the Egyptian use of materia medica. The first was 
observed in the processing and use of H. vulgare. In the uncharacteris-
tically more detailed directions of Eb. 206, ‘fresh/green’ and ‘undried’ 
barley (H. vulgare) (i.e capable of germination) is instructed to be ‘heated 
with water without letting it boil’ before being mixed with date seeds 
(P. dactylifera). Malted barley (H. vulgare) was used in ancient Egyptian 
beer manufacture, and dates (P. dactylifera) were perhaps one of the 
many ways in which the brew could be sweetened (Samuel, 2000; 
Metcalfe, 2016); however, to assume that Eb. 206 is simply a recipe for 
beer fails to acknowledge the potential therapeutic value and signifi-
cance of its inclusion within a prescribed remedy – not least because the 
text itself labels it ‘a secret method relevant to the physician’ (sp.w n. w 
šst r h ̱r.y swnw), and that ‘beer’ (ḥnq.t) and ‘sweet beer’ (ḥnq.t nḏm.t) are 
prescribed throughout the Egyptian medical texts (see examples in 
supplement; Metcalfe, 2016). The use of barley (H. vulgare) in Egyptian 
medicine is currently appreciated only as a potential vehicle for other 
pharmaceutically active ingredients (Germer, 2008); however, the value 
of this unusually detailed preparation method is comparable to a use of 
H. vulgare in the PPRC. Mai Ya 麦芽—the earliest citation of which is 
found in the Yaoxing Lun 药性论 (Treatise on the Nature of Medicinal 
Herbs) dating to the Tang Dynasty (7th Century CE) (Zhen, 2013)—is 
prepared in modern TCM by soaking the seed in water warmed to 
around 25–40 ◦C, until the sprout grows up to 0.5 cm. Unlike the 
Egyptian instructions, Mai Ya is then dried, stir-baked until browned and 
the Hordei Fructus Germinatus is removed, before being consumed. 
Despite the differences in preparation, the phytochemical processes 
involved during barley germination have a medicinal value. According 
to current research, germinating barley grains contain maltose and 
dextrin derived from the degradation of starch in the endosperm of the 
grain during its germination (Andriotis et al., 2016). Maltose and dextrin 
are able to mildly promote the secretion of gastric acid and pepsin in the 
stomach – these have a noticeable effect on treating abdominal cramps 
and diarrhea (Marieb and Hoehn, 2015). Based on the description from 
the PPRC (2015), dyspepsia is caused by the movement of qi being 
blocked by the digestive system; using H. vulgare promotes the circula-
tion of qi by improving the digestive function of the spleen-stomach 
system, thereby promoting the digestion of food. While the cultural 
models are unsurprisingly different, they share a common element: both 
traditions indicate the need to remedy a type of blockage or obstruction, 
perhaps indicating a universal in the perception of illness and health 
restoration in system-based traditions (see Scheid, 2018). 
Eb. 205 instructs the physician to administer his remedy for a 
digestive complaint ‘after it (the ra-ib or obstruction therein) has been 
soaked in “water of barley (H. vulgare)” (mw jt)’. The placement of the 
specification for preparing a liquid from germinating barley in Eb. 206 
(immediately following Eb. 205) might suggest that the former ‘water of 
barley’ is an abbreviation of the same instruction. Both texts point to-
wards treating a type of abdominal discomfort, suggesting that the se-
lection of this treatment was motivated by the specific symptom, though 
its efficacy was understood within the conceptualisation of the over-
arching explanatory model of an obstructed ra-ib. While the preparation 
methods of Mai Ya and the instructions Eb. 206 share interesting simi-
larities, they are not identical as ultimately the latter produces a drink; 
the limitations of our case-study therefore mark the need for further 
investigation. 
A second and basic parallel was observed with the use of the rhi-
zomes from Cyperus esculentus L. and Cyperus rotundus L. in the ra-ib texts 
(classified as wꜤḥ, there is no Egyptian distinction between rhizomes 
from C. esculentus and C. rotundus, both of which are abundantly present 
on the archaeobotanical record (de Vartavan and Amorós, 1997)) and 
the rhizome from C. rotundus in the PPRC. From Egyptian archaeological 
and pictorial evidence, the rhizomes were (and still are) used as a 
food-stuff in Egypt (Manniche, 1989). In the two occasions that the 
rhizome was prescribed in the ra-ib texts, it appears as a main ingredient 
(in both it is the first listed in the recipe, with 1/2 dja used in Eb. 205 and 
1 dja used in Eb. 212; though note that in Eb. 212 this is combined with 
an equal amount of raisins). While the ailment treated in Eb. 212 is 
unspecified, the symptoms of Eb. 205—the remedy, which first pre-
scribed ‘water of barley’ (H. vulgare), noted above—suggest treatment of 
digestive discomfort. In TCM, the rhizome of C. rotundus is used to 
distend pain in the chest and hypochondrium, as well as stiffness and 
oppression in the epigastrium and abdomen, treating distention and 
fullness. This result is consistent with the motivation for selecting ‘water 
of barley’ in Eb. 205, noted above. 
A third parallel was found in the use of species of Artemisia. 
Returning to Eb. 192 and 194, the remedy treating a patient who vomits 
considerably and whose symptoms are at his forehead ‘while his two 
eyes are inflamed and his nose runs’, our investigation suggests that the 
Egyptian motivations for the selection of materia medica were more 
complex than simply stimulating digestion or resolving abdominal 
discomfort. Aside from the aforementioned speculation about the sin-
gular use of onion to treat these symptoms, it was of particular interest to 
note that TCM uses Artemisia annua L. to treat malaria, fever, jaundice, 
and heat-stroke: symptoms of which are more attuned to those noted in 
Eb. 192 and 194. While the Egyptian diagnoses are explained as putre-
faction from an obstruction of setet-substance within the broader ra-ib 
systemic model, our investigation again suggested that it was the 
symptoms observed rather than the explanatory model itself which in 
this case directed the selection of onions (Allium cepa) and wormwood 
(Artemisia absinthium), to be consumed via the ra-ib. These symptoms are 
notably dissimilar from those noted above, further illuminating the 
system-based dynamic of how the Egyptians perceived remedies to work 
within the ra-ib model. 
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Table 1 





Egyptian applications in ra-ib cases (Eb. 
188–216; Sm. v) 
Ingredient used in TCM Medicinal applications in TCM 
Acacia Tree: 
šnd.t  
Acacia nilotica Delile. Leaf applied to the back for pain-relief (Eb. 
200); resin used in a drink to ‘invigorate his 
character’ when belly is narrowed (Eb. 205); 
resin and leaf used to remove an undefined 
‘obstruction in his right side’ (Eb. 210). 
Acacia catechu (L.f.) Willd. Hemostasis, wound treatment, cough and 
phlegm treatment, also treats eczema. 
Acacia Resin: 
qmy.t  
Onion: ḥḏ  Allium cepa L. Eaten to treat an obstruction of bodily-fluid 
(st.t) causing vomiting, inflamed eyes and a 
running nose (Eb. 192, 195). 
Allium chinense G. Don., or 
Allium macrostemon Bunt 
Used for chest/abdominal pain and angina 
pectoris, as well as diarrhea. 
Allium sativum L. Used for detoxification, removing swelling, as 
an insecticide, stopping diarrhea, dysentery, 
treating coughs, and for treating tuberculosis. 
Allium tuberosum Rottler ex 
Spreng. 
Special nutritional applications for liver and 
kidney systems concerning pain in waist and 
knees, also treats enuresis urinary frequency 
and white vaginal discharge. 
Artemisia: sꜤm  Artemisia absinthium L. Drunk to treat coughing believed to be 
caused by hardening under the flanks (Eb. 
190), and to cause a blood-clot to descend 
(Eb. 198); eaten to treat an obstruction of a 
bodily-fluid (st.t) causing vomiting, 
inflamed eyes and a running nose (Eb. 192, 
195). 
Artemisia argyi H.Lév. & 
Vaniot 
Used for hemostasis, as a pain killer, and to 
prevent itching. 
Artemisia annua L. Used against fever, heat stroke, malaria, and 
jaundice. 
Artemisia scoparia Waldst. 
& Kitam., or Artemisia 
capillaris Thunb. 
Used against heat stroke, jaundice, and to 
prevent itching. 
Incense: snṯr   Boswellia sp. 
(Boswellia sacra Flueck.? (syn.: 
Boswellia carteri Birdw.)) 
In a drink to remove an undefined 
‘obstruction in his right side’ (Eb. 210); 
eaten to treat an undefined obstruction (Eb. 
214, 216); in an auxiliary fumigation with 
Commiphora for lack of menstruation 
caused by an obstruction of blood in the 
uterus (Sm. v.) 
Boswellia sacra Flueck. 
(syn.: Boswellia carteri 
Birdw.; syn.: Boswellia 
bhaw-dajiana Birdw.) 
Used against dysmenorrhea and postpartum 
stasis; also used for pain relief and to activate 
the blood, incl. chest pain, stomach pain, pain 
in abdomen, and pain caused by rheumatism. 
Myrrh: Ꜥntjw  Commiphora sp. 
(Commiphora gileadensis (L.) C. 
Chr.? (syn.: Commiphora 
opobalsamum (L.) Engl.) 
Commiphora myrrha (Nees) 
Engl.?) 
Drunk to cause a blood-clot to descend (Eb. 
198); to remove a demonic obstruction in 
the right side causing unspecified symptoms 
(Eb. 209); mixed with other ingredients and 
applied to the vagina as an auxiliary 
treatment to make blood descend from the 
uterus; used in a further auxiliary 
fumigation for the same purpose (Sm. v.). 
Commiphora myrrha (Nees) 
Engl. (syn.: 
Commiphora molmol 
(Engl.) Engl. ex Tschirch). 
Used for dysmenorrhea, eye complaints acting 
upon the Liver Meridian, postpartum stasis; 
also for pain relief, incl. chest, stomach, or 
abdominal pains, and pain caused by 
rheumatism. Relieves stasis and swellings. 
Chufa: wꜤḥ  Rhizome of Cyperus esculentus L. 
or Cyperus rotundus L. 
Used in a drink to ‘revive his character’ 
when the belly is narrowed (Eb. 205); 
included against undefined obstruction (Eb. 
212). 
Cyperus rotundus L. Distending pain in the chest and the 
hypochondrium. Stiffness and oppression in 
the epigastrium and abdomen; treats distention 
and fullness. 
Fig: d  
b  
Ficus carica L. Drunk to remove an obstruction of faeces 
causing excessive vomiting (Eb. 202), and 
against another undefined obstruction (Eb. 
212). 
Ficus microcarpa L.f. Used as an anti-inflammatory and as an 
expectorant. Works well against coughs, 
chronic bronchitis, and asthma. 
Sycamore fig: 
nqꜤw.t   
Ficus sycomorus L. Drunk to remove an obstruction of faeces 
causing excessive vomiting (Eb. 202); and to 
make bad-meat which causes intense 
digestive complaints to descend through the 
body (Eb. 207); leaf and fruit drunk to treat 




Haematite Eaten in a remedy using red-coloured 
ingredients to eradicate thirst and cure the 
abstract ‘restlessness of his metaphorical 
heart’ (Eb. 197) 
Haematite Used against dizziness, tinnitus, vomiting, 
belching, hiccups, loss of breath, hematemesis, 
and epistaxis. 
Barley: jt  Hordeum vulgare L. Water/liquid of/from barley used to soak an 
obstruction causing digestive issues (Eb. 
205). Barley water prepared from 
germinating seeds, sweetened with dates, 
and drunk to treat discomfort from digestion 
caused by a bodily-fluid (st.t) obstruction 
(Eb. 206). 
Hordeum vulgare L. Stimulates digestion, releases food 
accumulation, and distends pain in the 
epigastrium and abdomen. 
Zizyphus: nbs  Ziziphus spina-christi (L.) Desf.. Bread from or fruit (Jujube) of applied 
topically to treat unspecified obstructions 
(208, 213); leaves drunk to treat an 
unknown obstruction (210). 
Ziziphus jujuba var. spinosa 
(Bunge) Hu ex H.F.Chou 
Special nutritional applications for the heart 
and liver systems. Relieves mental stress and 
good for sleep-loss and to stimulate dreaming. 
Ziziphus jujuba var. inermis 
(Bunge) Rehder 
Used for eating less, loose stool and asthenia.  
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The final fourth and fifth parallels were noted between the uses of 
species of both Boswellia and Commiphora. The Egyptian text (Edwin 
Smith verso 9) records a treatment for a woman ‘suffering from her ra-ib 
for whom nothing has come as menstruation’ – this is diagnosed as ‘an 
obstruction of blood in her uterine system’. The main part of the remedy 
was a drink from an indeterminable seed/fruit/powder (w m, 
) that was drunk alongside smearing the vagina with a mixture 
from an indeterminable quality of oil, cumin, galena, and myrrh 
(without reference of quantity) ‘which causes the blood to descend from 
her’. Should the first method prove unsuccessful, an unknown type of 
plant was then to be cooked in oil and smeared, and both myrrh 
(Commiphora (uncertain species, potentially myrrha (Nees) Engl., or 
giliadensis (L.) C. Chr (syn.: Commiphora opobalsamum (L.). Engl.), see 
Vartavan and Amorós, 1997)) and incense (Boswellia (uncertain species, 
potentially sacra Flueck (syn.: Boswellia carteri Birdw.), see Vartavan and 
Amorós, 1997).) were used to fumigate vagina. In the PPRC, both Bos-
wellia sacra Flueck. (syn.: B. carteri; syn.: Boswellia bhaw-dajiana Birdw.), 
and C. myrrha (syn.: Commiphora molmol (Engl.) Engl. ex Tschirch) are 
ingested orally to treat pain relief in the chest or abdominal regions, and 
pain caused by rheumatism; more significantly, both are used to treat 
dysmenorrhea. Again, though the method of application is ultimately 
dissimilar, the parallel motive is notable. 
A further philological question was raised by our investigation into 
the uses of these ingredients in both traditions. Elsewhere in TCM, 
B. sacra and C. myrrha are used against eye complaints; they are ingested 
to act upon the Liver Conduit. This treatment strategy centres on the 
connection of this conduit to the eyes (a connection also made in bio-
medicine—dry, red, or itchy eyes being symptomatic of liver dysfunc-
tion—and developmental biology, which suggests the connection is 
embryogenetic (Keeton and Gould, 1986)). Z- and E-guggulsterones 
derived from the Commiphora genus have been found to exert their 
anti-inflammatory properties by suppressing activation of NF-κB and 
expression of NF-κB-regulated gene products and thereby preventing the 
expression of inflammation related protein in eye tissues (Shen et al., 
2012)). Unlike in TCM, the Egyptian sources do not impart direct ex-
planations as to why ingredients are used; in the ancient source material 
incense (B. sacra) and myrrh (C. gileadensis and/or C. myrrha) were 
employed as ingredients in prescriptions which omit symptom de-
scriptions entirely. Each have a wider use in the Egyptian healing 
compendia outside of the source material studied here; both were 
applied topically to treat burns, wounds, and swellings; myrrh was 
applied externally in a selection of eye remedies, and incense ingested to 
treat the belly, liver, extremities, and skin (Germer, 2008). Eb. 210, 214, 
and 216 include incense in remedies to be consumed, and in Eb. 209 
myrrh was consumed to fight an obstruction believed to be caused by a 
demon without further symptom specification. While their frequent 
usage in topical applications for burns, wound treatments, and swellings 
suggests that the effects of their antibacterial or anti-inflammatory 
properties were recognised, their use in a systems-based tradition ne-
cessitates further consideration of the explanatory models within which 
the remedies were understood to operate (cf. Pommerening, 2017b). An 
alternative method of treatment for extremities and symptoms in other 
areas of the body might therefore be by being consumed to act upon the 
ra-ib to treat those areas with which the ra-ib is connected, much like 
treatments in TCM to treat the eyes by acting upon the Liver Conduit. 
Rather than solely explaining their frequent use exclusively with cul-
tural semiotics (i.e. because incense and myrrh were used in religious 
ceremonies), this analysis further presents a theoretical paradigm 
established from an emic perspective for consideration – a perspective 
which does not obviously translate for the layman acquainted only with 
an elementary understanding of modern medicine. 
4. Conclusions 
Readjusting our understanding of ra-ib from ‘stomach’ to an ‘inner 
thoroughfare’, running from the mouth to the anus, answers our first 
question concerning the limits of this system. It not only better fits the 
lexical components of the term itself, it also fits the metaphors employed 
to illustrate the problems caused by the obstruction of the system (such 
as the use of riverine terminology). These inferences indicate how the 
system itself was conceptualised, providing an answer to our second 
question. This significantly alters the manner in which we understand 
the Egyptian perspective of the body, at least in a healing context – its 
physiological processes, and the selection of materia medica, the third 
and final question posed during our investigation. The latter’s diversity 
reflects the range of symptoms whose origin was explained as an 
obstruction to the more holistic system. The result of this is a potential 
conceptual blending between the selection of ingredients preconceived 
as being useful for treating the specific symptoms manifesting in diverse 
regions of the body, and those which were known to increase digestion 
to varying degrees and therefore perhaps more focused on remedying 
the perceived cause of the illness – the obstruction of the inner thor-
oughfare and the need to push this cause downward through the body, 
as implied by many passages within the ra-ib series. 
In certain cases, our comparative analysis with TCM and the PPRC 
suggested particular materia medica could have been selected in accor-
dance with symptoms, such as A. absinthium for symptoms familiar to the 
illnesses for which the PPRC prescribes other species of Artemisia 
(notably A. annua), and B. sacra and C. myrrha for symptoms familiar to 
dysmenorrhea, for which the PPRC also prescribes these resins (though 
again it must be noted that the application methods are distinctly 
different). Similar symptom-based motivations would therefore exist for 
the selection of ingredients in the other prescriptions within the ra-ib 
series, for which no parallels in the PPRC were identified, as well as in 
the more basic prescriptions found elsewhere in the large corpus of 
ancient Egyptian remedies which typically forego any inclusion of 
symptoms or diagnoses. The striking parallel in the processing and use of 
H. vulgare could be consistent with this as its use potentially points to-
wards symptoms of digestive discomfort, against which the processed 
product had been observed empirically as a useful treatment. However, 
the preparation’s potential ability to stimulate digestion might also be 
consistent with the need to remove and ‘make descend’ the cause of 
illness—the obstruction to the thoroughfare—in order to restore health, 
suggesting the explanatory model motivated the treatment strategy. Of 
course from an Egyptian perspective, the motivation for selecting in-
gredients based on any empirical observation of their efficacy against 
certain symptoms and the motivation for selecting ingredients based on 
the perspective of the explanatory model need not be mutually exclu-
sive. Rather, certain ingredients could have been perceived as being 
useful for removing certain types of obstructions—such as the use of 
A. absinthium and A. cepa for that caused by the ‘setet-substance’, against 
which they were used in Eb. 192 and 194—which were diagnosed ac-
cording to particular types of symptoms. This helps to explain the di-
versity of ingredients and potentially even ingredient clusters prescribed 
in the remedies which make up the ra-ib series. For now, quite how 
pervasive this concept of obstruction is to the Egyptian culture (i.e., 
beyond the ra-ib texts) is yet to be determined by ongoing research, 
though its significance in these texts could hint at a potential relative 
universal within traditions which generally have a more systemic 
perspective, where health is equated with free-flow (as seen with tong in 
TCM, Scheid, 2018) and the absence of obstructions (as with shena) in 
bodily systems. Indeed, future comparative investigations would be 
needed to confirm such a potentially generalist hypothesis. 
Finally, beyond the parallels observed in the internal usage of materia 
medica, the study also suggests that this Egyptian perspective—that of 
the inner thoroughfare and the areas of the body where illnesses asso-
ciated with it manifest as symptoms—could further explain the ingestion 
of certain ingredients more commonly used elsewhere in the corpus for 
topical applications, such as the use of B. sacra and C. gileadensis and/or 
myrrha for burns or wounds. Whereas in modern TCM the internal 
application of the natural products associated with specific extremities is 
proven by clinical experimentation (such as the use of C. myrrha acting 
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upon the liver conduit to treat inflammation of the eyes), empirical 
reasoning does not necessarily always need to justify the Egyptian mo-
tivations for treatment selection, which could in cases potentially 
operate on the basis of its explanatory models and systemic perspectives 
of the body alone. 
In closing, the relative universals outlined by our study were not only 
found in the types and motivations of ingredient selection between these 
two disconnected cultures, but more importantly in the system-based 
paradigms by which they understand efficacy, whether accurately or 
otherwise. It is this which qualifies dynamic philological considerations 
for future attempts at exploring ancient motivations for the selection of 
treatment strategies. 
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Germer, R., 2008. Handbuch der altägyptischen Heilpflanzen. Philippika, Wiesbaden.  
Heinrich, M., Lardos, A., Leonti, M., Weckerle, C., Willcox, M., Applequist, W., Ladio, A., 
Lin Long, C., Mukherjee, P., Stafford, G., 2018. Best practice in research: consensus 
statement on ethnopharmacological field studies – ConSEFS. J. Ethnopharmacol. 
211, 329–339. 
Heydari, M., Hashempur, M.H., Ayati, M.H., Quintern, D., Nimrouzi, M., Mosavat, S.H., 
2015. The use of Chinese herbal drugs in Islamic medicine. J. Integr. Med. 13 (6), 
363–367. 
Hornung, E., 1963. Das Amduat: Die Schrift des Verborgenen Raumes 1: Text. Otto 
Harrassowitz, Wiesbaden.  
Imhausen, A., Pommerening, T., 2010. Introduction: translating ancient scientific texts. 
In: Imhausen, A., Pommerening, T. (Eds.), Writings of Early Scholars in the Ancient 
Near East, Egypt, Rome, and Greece. 
Jouanna, J., 1999. Egyptian medicine and Greek medicine. In: Jouanna, J. (Ed.), Greek 
Medicine from Hippocrates to Galen: Selected Papers. Brill, Leiden, pp. 3–20. 
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Lexikographie des Ägyptischen-Koptischen: Akten der Leipziger Abschlusstagung des 
Akademienprojekts “Altägyptisches Wörterbuch”, vol. 84. ASAWL, Leipzig, 
pp. 82–111. 
Pommerening, T., 2017a. Classification in ancient Egyptian medical formulae and its role 
in Re-discovering comprehensive and specific concepts of drugs and effects. In: 
Pommerening, T., Bisang, W. (Eds.), Classification from Antiquity to Modern Times: 
Sources, Methods, and Theories from an Interdisciplinary Perspective. De Guyter, 
Berlin, pp. 167–195. 
Pommerening, T., 2017b. Medical Re-enactments: ancient Egyptian prescriptions from 
an emic view. In: Rosati, G., Guidotti, M. (Eds.), Proceedings of the XIth Congress of 
Egyptologists, Florence, Italy. Archaeopress, Oxford, pp. 519–526, 23.-30.08.2015.  
Pommerening, T., Bisang, W., 2017. Classification and categorization through time. In: 
Pommerening, T., Bisang, W. (Eds.), Classification from Antiquity to Modern Times: 
Sources, Methods, and Theories from an Interdisciplinary Perspective. De Guyter, 
Berlin, pp. 1–17. 
Pormann, P., Savage-Smith, E., 2007. Medieval Islamic Medicine. Edinburgh University 
Press, Edinburgh.  
Quinlan, M., 2015. Ethnomedicine. In: Singer, M., Erickson, P. (Eds.), A Companion to 
Medical Anthropology. Wiley Blackwell, Chichester, pp. 381–403. 
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Wink, M., 2015. Modes of action of herbal medicines and plant secondary metabolites. 
Medicine 2, 251–286. 
Wu, X.-N., 1998. Current concept of spleen-stomach theory and spleen deficiency 
syndrome in TCM. World J. Gastroenterol. 15 (1), 2–6, 4.  
Yuan, Y., Xiaobei, M., 2020. Modern research progress and new discussion of Li 
dongyuan’s theory of the spleen and stomach. J. New Chinese Med. 52 (2), 22–25. 
Zhao, Z., Liang, Z., Chan, K., Lu, G., Lee, E.-L.-M., Chen, H., Li, L., 2010. A unique issue in 
the standardization of Chinese materia medica: processing. Planta Med. 76 (17), 
1975–1986. 
Zhen, Q., 2013. Treatise on the Nature of Medicinal Herbs. China Press of Traditional 
Chinese Medicine, Beijing.  
J. Russell et al.                                                                                                                                                                                                                                  
